COMMUNIQUÉS West-GlobeNewswire

Global Health Congress 2026 Convenes Health System Leaders, Clinicians, Technologists, Investors and Innovators at the Yale Club of New York City, October 9th-11th
25/09/2026
The three-day congress features keynote speaker Robert Herjavec and a live Venture Forum where healthcare founders pitch to investors and strategic partners. NEW YORK, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Global Health [...]
Chrysalis Health and Curaechoice Join Forces to Address Cost and Access Barriers to Mental Health Care
26/09/2026
Strategic collaboration expands no-cost access to trusted in-person and virtual mental health services, helping employers simplify care while improving affordability and access for employees and their families. [...]
Pharming announces U.S. FDA acceptance and Priority Review of sNDA for lower doses of Joenja® to treat children with APDS
25/09/2026
If approved, J oenja would be available to eligible patients aged 4 years and older with APDS who weigh 13 kg or more Decision follows recent approval of Joenja for children aged 4 to 11 years with APDS weighing at [...]
Newron Provides Update on Phase 3 ENIGMA-TRS 2 Study
25/09/2026
Ad hoc announcement pursuant to Art. 53 LR U.S. clinical hold remains in place; study continues in all other countries Company initiates expansion of clinical sites and enrollment in Europe, Asia and Latin America [...]
OneMedNet Corporation Announces 1-for-10 Reverse Stock Split
25/09/2026
MINNEAPOLIS, Sept. 25, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (the “Company,” “we,” or “our”), a leading provider of first-party (direct-from-source) regulatory decision-grade, AI-driven Real- [...]
Orion Corporation: Acquisition of own shares during week 39, 2026
25/09/2026
Orion Corporation: Acquisition of own shares during week 39, 2026 The share buybacks form part of the share buyback programme that Orion Corporation announced on 27 August 2026. The buyback programme runs from 1 [...]
SELLAS Life Sciences Presents Preclinical Data Demonstrating SLS009 Activity in Pancreatic Cancer Models at the 2026 AACR Conference on Pancreatic Cancer
25/09/2026
SLS009 increased apoptosis more than six-fold versus daraxonrasib in a MYC-amplified, daraxonrasib-resistant patient-derived pancreatic cancer organoid model - Combination of SLS009 and daraxonrasib further increased [...]
Annamycin Turns “Cold” Pancreatic Tumors “Hot” in New Preclinical Data Presented at AACR
25/09/2026
Data presented at the AACR Conference on Pancreatic Cancer indicate Annamycin’s antitumor activity is partially mediated by CD8+ T cells, supporting a potential immune-mediated mechanism alongside its direct cytotoxic [...]
Single infusion of CARVYKTI®▼ (ciltacabtagene autoleucel) delivered five-year treatment-free remissions in 50% of patients in early line relapsed/refractory multiple myeloma
25/09/2026
New results from cohort A of the CARTITUDE-2 study, among 20 patients, suggest earlier treatment may increase the likelihood of long-term remission 1 Study adds to Johnson & Johnson's overwhelming body of evidence [...]
Cerenome to Hold CNSide® Business Update Call on September 30, 2026
25/09/2026
Management to provide updates on recent developments including diagnostic billing, market access & growth plans HOUSTON, Sept. 25, 2026 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly-owned subsidiary of [...]
Firefly (NASDAQ: AIFF) and NeuroSigma Partner to Expand Access to First FDA-Cleared, Non-Drug Treatment for Pediatric ADHD
25/09/2026
– Partnership will introduce NeuroSigma’s second-generation Monarch eTNS ® System to Firefly’s nationwide network of Evoke™ clinicians – – Collaboration brings together an FDA-cleared pediatric ADHD treatment and [...]
neurocare and Wave Neuroscience partner to expand patient access to FDA-Cleared MeRT® therapy for PTSD on the Apollo TMS Therapy System
25/09/2026
Munich, Germany and Alpharetta, GA, United States, September 25, 2026 - neurocare group AG (“neurocare” or the “Company”), a best practice platform for mental health and performance, and the company behind the neurocare [...]
Adaptive Biotechnologies Highlights Role of Highly Sensitive MRD Testing in New International Myeloma Society Definition of Cure
25/09/2026
Definition requires five years off myeloma treatment with sustained MRD negativity, assessed with technology sensitive enough to identify one myeloma cell among one million cells SEATTLE, Sept. 25, 2026 (GLOBE NEWSWIRE [...]
CDT Equity Inc. Announces Reverse Stock Split
25/09/2026
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Sept. 25, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), announces that its board of directors has approved a 1-for-25 reverse stock split of [...]
Teladoc Health Announces Chief Legal Officer Transition
25/09/2026
Jonathan Dorfman to be promoted to Chief Legal Officer and Secretary effective November 2, 2026 NEW YORK, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today [...]
Knowtex, the First Frontier AI Lab for Healthcare, Named Prime Awardee on VA's Nine-Figure Ambient Scribe Enterprise Contract
25/09/2026
One of two prime awardees on the $775.72 million multiple-award IDIQ, Knowtex is expanding AI that gives clinicians more time with Veterans. It's already live at 79 VA medical centers and more than 310 VA facilities [...]
INVO Fertility to Participate in the Lytham Partners Fall 2026 Investor Conference
25/09/2026
SARASOTA, Fla., Sept. 25, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) ("INVO Fertility" or the "Company"), a healthcare fertility company focused on the establishment, acquisition, and operation of [...]
Tilray Brands to Announce First Quarter Fiscal Year 2027 Financial Results on October 8, 2026
25/09/2026
NEW YORK and LONDON and LEAMINGTON, Ontario, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc . (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the [...]
SBC Medical to Participate in Several Upcoming Investor Conferences in October 2026
25/09/2026
IRVINE, Calif., Sept. 25, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“The Company” or “SBC Medical”), a Medical Services Organization (MSO) providing management support across a wide [...]

Pages